Risk Factors of Renal Failure in HIV Patients at Initiation of ARV Treatment: Retrospective Study of 3118 Patients Followed in Infectious Diseases Department at Lomé University Hospital
- 1 Department of Nephrology and Hemodialysis, CHU Sylvanus Olympio, Lome, Togo
- 2 Department of Nephrology and Hemodialysis, CHU Sylvanus Olympio, Lome, Togo
- 3 Department of Nephrology and Hemodialysis, CHU Sylvanus Olympio, Lome, Togo
- 4 Department of Nephrology and Hemodialysis, CHU Sylvanus Olympio, Lome, Togo
- 5 Department of Nephrology and Hemodialysis, CHU Sylvanus Olympio, Lome, Togo
- 6 Department of Nephrology and Hemodialysis, CHU Sylvanus Olympio, Lome, Togo
- 7 Department of Dermatology and Venerology, CHU Sylvanus Olympio, Lome, Togo
Abstract
HIV infection is a major cause of chronic kidney disease, associated with high morbidity and mortality in sub-Saharan Africa. The objective of this study is to assess the prevalence and risk factors of renal disease at initiation of antiretroviral therapy. This was a descriptive and analytical retrospective study carried out in the infectious and tropical diseases department at Sylvanus Olympio University Hospital. The data have been extracted from the ESOPE software. Kidney disease was defined by a GFR, estimated by MDRD (Modification of Diet in Renal Disease) formula, less than 60 ml/min/1.73 m 2 . Risk factors associated with kidney disease were assessed using univariate and multivariate analysis. There were 3118 HIV-infected patients included in our study. The median estimated filtration rate was 94.7 ml/min/1.73 m 2 : 2.9% had an eGFR < 15 ml/min/1.73 m 2 . 1303 had kidney disease (41.8%). Most patients (30.8%) were in the WHO clinical stage 1. The median CD4 count was 165/μL [IQR = 72 - 274/μL]; the median hemoglobin level was 10.4 g/dL [IQR = 8.8 - 11.9 g/dL]; all patients had thrombocytopenia less than 100.000/mm 3 ; 8.5% had leukocytosis greater than 10.000/mm 3 . Most of patients had HIV1. In the multivariate analysis, age greater than 40 years (p < 0.0001), and female gender and hyperleukocytosis greater than 10,000/mm 3 were significantly associated with renal disease. The prevention of kidney disease must go through the identification of its risk factors in the target populations.
- Rao, T.S., Filippone, E.J., Nicastri, A.D., Landesman, S.H., Frank, E., Chen, C.K., et al. (1984) Associated Focal and Segmental Glomerulosclerosis in the Acquired Immunodeficiency Syndrome. The New England Journal of Medicine, 310, 669-673. https://doi.org/10.1056/NEJM198403153101101
- Nochy, D. (1997) L’atteinte rénale au cours de l’infection par le VIH 1. Presse Médicale, 26, 91-95.
- Han, T.M., Naicker, S., Ramdial, P.K. and Assounga, A.G. (2006) A Cross-Sectional Study of HIV-Seropositive Patients with Varying Degrees of Proteinuria in South Africa. Kidney International, 69, 2243-2250. https://doi.org/10.1038/sj.ki.5000339
- Wools-Kaloustian, K., Gupta, S.K., Muloma, E., Owino-Ong’or, W., Sidle, J., Aubrey, R.W., et al. (2007) Renal Disease in an Antiretroviral-Naive HIV-Infected Outpatient Population in Western Kenya. Nephrology Dialysis Transplantation, 22, 2208-2212. https://doi.org/10.1093/ndt/gfm223
- Ekat, M.H., Courpotin, C., Diafouka, M., Akolbout, M., Mahambou-Nsonde, D., Bitsindou, P.R., et al. (2013) Prévalence et facteurs associés à l’insuffisance rénale chez les patients nouvellement dépistés VIH-positifs à Brazzaville (République du Congo). Médecine et Santé Tropicales, 23, 176-180.
- UNESCO HIV and Health Education Clearinghouse (2015) Plan opérationnel de lutte contre le Sida et les IST au Togo 2014-2015. 14-15.
- Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. and Roth, D. (1999) A More Accurate Method to Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Annals of Internal Medicine, 130, 461-470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002
- Levey, A.S. and Coresh, J. (2012) Chronic Kidney Disease. The Lancet, 379, 165-180. https://doi.org/10.1016/S0140-6736(11)60178-5
- Msango, L., Downs, J.A., Kalluvya, S.E., Kidenya, B.R., Kabangila, R., Johnson Jr., W.D., et al. (2011) Renal Dysfunction among HIV-Infected Patients Starting Antiretroviral Therapy in Mwanza, Tanzania. AIDS (London, England), 25, 1421. https://doi.org/10.1097/QAD.0b013e328348a4b1
- Anyabolu, E.N., Chukwuonye, I.I., Arodiwe, E., Ijoma, C.K. and Ulasi, I. (2016) Prevalence and Predictors of Chronic Kidney Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Owerri, Nigeria. Indian Journal of Nephrology, 26, 10. https://doi.org/10.4103/0971-4065.156115
- Mouhari-Toure, A., Patassi, A., Nabroulaba, K.T., Djadou, K.E., Edou, K., Nyametso, D., et al. (2011) Profil biologique des patients adultes infectés par le VIH à l’initiation du traitement antirétroviral au Togo. Médecine et Maladies Infectieuses, 41, 229-234. https://doi.org/10.1016/j.medmal.2010.11.007